Drug Trial Radar · NCT07632157
MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
196
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Wake Forest University Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 8, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).
Conditions
- Atrial Flutter With Rapid Ventricular Response
Interventions
Magnesium Sulfate 2gDrug
Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
Magnesium Sulfate 4gDrug
Magnesium Sulfate 4g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular response (AFF RVR)
Saline (0.9% NaCl)Drug
The control group will receive a bolus of normal saline of the same volume and infused over 15 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ventricular rate controlTime frame: Within the first 2 hours of intravenous magnesium administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Advocate Christ Medical Center Emergency Department (ACMC ED)
Oak Lawn, Illinois · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.